CBNK(CBNK)
CBNK
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $268M | $295M |
| Low | $267M | $293M |
| High | $268M | $296M |
| EBITDA Avg | $78M | $84M |
| Low | $78M | $84M |
| High | $79M | $87M |
| EBIT Avg | $75M | $81M |
| Low | $75M | $81M |
| High | $76M | $84M |
| Net Income Avg | $57M | $62M |
| Low | $57M | $61M |
| High | $58M | $64M |
| EPS Avg | $3.47 | $3.80 |
| Low | $3.44 | $3.72 |
| High | $3.50 | $3.87 |
| Analysts (Rev / EPS) | 3 / 4 | 3 / 4 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $69M | $71M | $70M | $73M | $75M | $77M |
| Low | $68M | $71M | $70M | $72M | $75M | $76M |
| High | $69M | $71M | $71M | $73M | $76M | $77M |
| EBITDA Avg | $21M | $22M | $20M | $21M | $22M | $22M |
| Low | $20M | $21M | $20M | $21M | $22M | $22M |
| High | $21M | $22M | $20M | $21M | $22M | $22M |
| EBIT Avg | $20M | $21M | $19M | $20M | $21M | $21M |
| Low | $19M | $20M | $19M | $20M | $21M | $21M |
| High | $20M | $21M | $19M | $20M | $21M | $21M |
| Net Income Avg | $15M | $16M | $15M | $15M | $16M | $16M |
| Low | $15M | $15M | $15M | $15M | $16M | $16M |
| High | $15M | $16M | $15M | $16M | $16M | $16M |
| EPS Avg | $0.91 | $0.96 | $0.89 | $0.94 | $0.98 | $0.98 |
| Low | $0.90 | $0.94 | $0.89 | $0.93 | $0.97 | $0.98 |
| High | $0.92 | $0.97 | $0.90 | $0.95 | $0.99 | $0.99 |
| Analysts (Rev / EPS) | 3 / 3 | 3 / 3 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |